Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?

Clinical Rheumatology

Volumn 27, Issue 5, 2008, Pages 565-572

  Korczowska, Izabela ^a   Olewicz Gawlik, Anna ^a   Trefler, Jakub ^b   Hrycaj, Paweł ^a   Krzysztof Łącki, Jan ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

Glucocorticoids; Markers of osteoporosis; Osteoporosis; Rheumatoid arthritis

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; CREATININE; CYCLOSPORIN A; DEOXYPYRIDINOLINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ESTROGEN; GLUCOCORTICOID; GOLD SALT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OROSOMUCOID; OSTEOCALCIN; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT COURSE THERAPY;

EID: 41849140021     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0747-2     Document Type: Article

References (44)

1. Pincus T (1994) Rheumatoid arthritis: A medical emergency? Scand J Rheumatol 23:21-30
2. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinhexel SM, Cathey MA (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 4:481-494
3. Ła̧cki JK, Sobieska M, Leszczynski P, Wiktorowicz K (1994) Microheterogenity of alpha 1-acid glycoprotein in rheumatoid arthritis patients treated with methotrexate. Ann Rheum Dis 53:480
4. Hamalainen H, Kautiainen H, Kaarela K, Kotaniemi A (2005) The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis. Clin Exp Rheumatol. 23(2):193-198
5. Anon G (1993) Consensus development conference: Diagnosis, prophilaxis, and treatment of osteoporosis. Am J Med 94:646-650
6. Parfit AM (1983) The physiological and clinical significance of bone histomorphometric data. In: Recker R (ed) Bone histomorphometry, technics and interpretation. CRC Press, Boca Raton, pp 143-223
7. Fujita T, Matsui T, Nakao Y, Shiozawa S, Imai Y (1990) Cytokines and osteoporosis. Ann NY Acad Sci 587:371-375
8. Eriksen EF (1986) Normal and pathological remodelling of human trabecular bone: Three dimensional reconstruction of the remodelling sequence in normal and in metabolic bone disease. Endocrine Rev 7:379-408
9. Hall GM, Spector TD, Griffin AJ, Jawad AS, Hall ML, Doyle DV (1993) The effect of rheumatoid arthritis and steroides therapy on bone density in postmenopausal women. Arthritis Rheum 36:1510-1516
10. Watts NB (1999) Clinical utility of biochemical markers of bone remodeling. Clin Chem 45:1359-1368
11. Armour KJ, Armour KE, van't Hof RJ, Reid DM, Wei XQ, Liew FY, Ralston SH (2001) Activation of the inducible nitric oxide synthase pathway to inflammation-induced osteoporosis by supressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 44(12):2790-2796
12. Rico H, Herandez ER, Gomez-Castresana F, Yague M, Cabranes JA, Valor R (1990) Osteopenia in rheumatoid arthritis: A biochemical, hormonal and histmorphometric study. Clin Rheumatol 9:63
13. Suzuki Y, Mizushima Y (1997) Osteoporosis and rheumatoid arthritis. Osteoporosis Int 7(Suppl 3):S217-22
14. Habib GS, Haj S (2005) Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids. Clin Rheumatol 24(2):129-133
15. Tascioglu F, Colak O, Armagan O, Alatas O, Oner C (2005) The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: A comparison of alendronate and intranasal salmon calcitonin. Rheumatol Int 26(1):21-29
16. Roldan JF, Del Rincon I, Escalante A (2006) Loss of cortical bone from the metacarpal diaphysis in patients with rheumatoid arthritis: independent effects of systemic inflammation and glucocorticoids. J Rheumatol 33(3):508-516
17. Als OS, Christiansen C, Hellesen C (1984) Prevelance of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment. Clin Rheumatol 3:201-208
18. Kroger H, Penttila IM, Alhava EM (1993) Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 22:172
19. Charles P, Poser JW, Mosekilde L, Jensen FT (1985) Estimation of bone turnover evaluated by 47 calcium kinetics: Efficiency of serum bone gamma-carboxyglutamic acid containing protein, serum alkaline phosphatase and urinary hydroxyproline excertion. J Clin Invest 76:2254-2258
20. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Głowacki J, Abiser JL, Apperley JF (1994) Interleukin-1 β-modulated gene expression in immortalized human chondrocytes. J Clin Invest 94:2307-2316
21. Bocquet J, Daireaux M, Langris M, Jouis V, Pujol JP, Beliard R, Loyau G (1986) Effect of a interleukin-1 like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes. Biochem Biophys Res Commun 134:539-549
22. Goldring MB, Birkhead JR, Sandell LJ, Kimura T, Krane SM (1988) Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 82:2026-2037
23. Ishimi Y, Miyaura C, Jin CH, Akashu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303
24. Gertzbein SD, Lance EM (1976) The stimulation of lymphocytes by chondrocytes in mixed cultures. Clin Exp Immunol 24:102-109
25. Ralston SH, Russell RG, Gowen M (1990) Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 5:983-988
26. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N (1995) Modulation of osteoclast differentiation by local factors. Bone 17:87S-91S
27. Ła̧cki JK (2000) Management of the patients with severe refractory rheumatoid arthritis: Are the never treatment options worth considering. BioDrugs 13:425-435
28. Ła̧cki JK, Klama K, Mackiewicz SH, Mackiewicz U, Muller W (1995) Circulating interleukin-10 and intrleukin-6 serum levels in rheumatoid arthritis patients treated with methotrexate or gold salts. Preliminary report. Inflamm Res 44:24-26
29. Oelzner P, Franke S, Muller A, Hein G, Stein G (1999) Relationship between soluble markers of immune activation and bone turnover in postmenopausal woman with rheumatoid arthritis. Rheumatology Oxford 38:841-847
30. Butler RC, Davie MW, Worsfold M, Sharp CA (1991) Bone mineral content in patients with rheumatoid arthritis: Relationship to low dose steroid therapy. Br J Rheumatol 30:86-90
31. Olbright T, Benker G (1993) Glucocorticosteroid induced osteoporosis: pathogenesis, prevention and treatment with special regard to the rheumatic diseases. J Int Med 234:237
32. Adachi DJ, Olszynski W, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, Brown J, Cowden EA, Goltzman D, Ioannidis G, Josse RG, Ste-Marie LG, Tenenhouse AM, Davison KS, Blocka KLN, Pollock P, Sibley J (2000) Management of corticosteroid-induced osteoporosis. Sem Arthr Rheum 4:228-251
33. McLaughlin F, Mackintosh J, Hayes BP, McLaren A, Uings IJ, Salmon P, Humphreys J, Meldrum E, Farrow SN (2002) Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers. Bone 30(6):924-930
34. Westhovens R, Dequeker J (2000) Rheumatoid arthritis and osteoporosis. Z Rheumatol 59(Suppl 1):33-38
35. Cortet B, Flipo RM, Pigny P, Duquesnoy B, Racadot A, Boersma A, Delcambre B (1997) How useful are bone turnover markers in rheumatoid arthritis? Rev-Rhum 64:153-159
36. Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Nguyen T, Emery P (1998) Osteoclastic activation is the principial mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 25:1282-1289
37. Hakala M, Aman S, Luukkainen R, Risteli L, Kauppi M, Nieminen P, Risteli J (1995) Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis 54:886-890
38. Kroger H, Risteli J, Risteli L, Penttila I, Alhava E (1993) Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann Rheum Dis 52:338
39. Saag KG (2002) Glucocorticoid use in rheumatoid arthritis. Curr Rheumatol Rep 4(3):218-25
40. Kollerup G, Hansen M, Horslev-Peterson K (1994) Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. Br J Rheumatol 33:816-820
41. Bijlsma JW, Van Everdingen AA, Huisman M, De Nijs RN, Jacobs JW (2002) Glucocorticoids in rheumatoid arthritis: Effects on erosions and bone. Ann N Y Acad Sci 966:82-90
42. van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW (2002) Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficiacy, disease-modifying properties, and side effects: A randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 136(1):1-12
43. Laan RF, Jansen TL, van Riel PL (1999) Glucocorticosteroides in the management of rheumatoid arthristis. Rheumatology 38:6
44. van Everdingen AA, Siewertsz Van Reesema DR, Jacobs JW, Bijlsma JW (2003) Low dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures? Clin Exp Rheumatol 21:145-147